pubmed-article:3403105 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:3403105 | lifeskim:mentions | umls-concept:C0001675 | lld:lifeskim |
pubmed-article:3403105 | lifeskim:mentions | umls-concept:C0001792 | lld:lifeskim |
pubmed-article:3403105 | lifeskim:mentions | umls-concept:C2349001 | lld:lifeskim |
pubmed-article:3403105 | lifeskim:mentions | umls-concept:C0001554 | lld:lifeskim |
pubmed-article:3403105 | lifeskim:mentions | umls-concept:C0681850 | lld:lifeskim |
pubmed-article:3403105 | lifeskim:mentions | umls-concept:C1706203 | lld:lifeskim |
pubmed-article:3403105 | lifeskim:mentions | umls-concept:C2697811 | lld:lifeskim |
pubmed-article:3403105 | lifeskim:mentions | umls-concept:C0031990 | lld:lifeskim |
pubmed-article:3403105 | lifeskim:mentions | umls-concept:C1550501 | lld:lifeskim |
pubmed-article:3403105 | lifeskim:mentions | umls-concept:C0201734 | lld:lifeskim |
pubmed-article:3403105 | lifeskim:mentions | umls-concept:C0053407 | lld:lifeskim |
pubmed-article:3403105 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:3403105 | pubmed:dateCreated | 1988-9-15 | lld:pubmed |
pubmed-article:3403105 | pubmed:abstractText | The age effect on the kinetics of piroxicam at the steady-state after oral administration of piroxicam beta-cyclodextrin was evaluated. The mean plasma concentration of piroxicam at the steady-state was significantly higher in elderly subjects (9.30 +/- 0.69 micrograms/ml mean +/- s.e.) than in younger adults (6.24 +/- 0.58 micrograms/ml mean +/- s.e.). Even though the distribution volume tended to be lower in elderly subjects (106.37 ml/kg), it did not show substantial differences in the two groups whereas the correlation between clearance and age was significant (p less than 0.05). It is therefore confirmed that piroxicam beta-cyclodextrin has the same pharmacokinetic behaviour at the steady-state in elderly subjects, as the active principle in a non-complexed form. | lld:pubmed |
pubmed-article:3403105 | pubmed:language | eng | lld:pubmed |
pubmed-article:3403105 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3403105 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:3403105 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3403105 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3403105 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3403105 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3403105 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:3403105 | pubmed:issn | 0251-1649 | lld:pubmed |
pubmed-article:3403105 | pubmed:author | pubmed-author:D'AmbrosioEE | lld:pubmed |
pubmed-article:3403105 | pubmed:author | pubmed-author:BoscariniMM | lld:pubmed |
pubmed-article:3403105 | pubmed:author | pubmed-author:ScaliGG | lld:pubmed |
pubmed-article:3403105 | pubmed:author | pubmed-author:CesariFF | lld:pubmed |
pubmed-article:3403105 | pubmed:author | pubmed-author:BonatiCC | lld:pubmed |
pubmed-article:3403105 | pubmed:author | pubmed-author:BufalinoLL | lld:pubmed |
pubmed-article:3403105 | pubmed:author | pubmed-author:AcerbiDD | lld:pubmed |
pubmed-article:3403105 | pubmed:author | pubmed-author:MansantiPP | lld:pubmed |
pubmed-article:3403105 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:3403105 | pubmed:volume | 8 | lld:pubmed |
pubmed-article:3403105 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:3403105 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:3403105 | pubmed:pagination | 175-80 | lld:pubmed |
pubmed-article:3403105 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
pubmed-article:3403105 | pubmed:meshHeading | pubmed-meshheading:3403105-... | lld:pubmed |
pubmed-article:3403105 | pubmed:meshHeading | pubmed-meshheading:3403105-... | lld:pubmed |
pubmed-article:3403105 | pubmed:meshHeading | pubmed-meshheading:3403105-... | lld:pubmed |
pubmed-article:3403105 | pubmed:meshHeading | pubmed-meshheading:3403105-... | lld:pubmed |
pubmed-article:3403105 | pubmed:meshHeading | pubmed-meshheading:3403105-... | lld:pubmed |
pubmed-article:3403105 | pubmed:meshHeading | pubmed-meshheading:3403105-... | lld:pubmed |
pubmed-article:3403105 | pubmed:meshHeading | pubmed-meshheading:3403105-... | lld:pubmed |
pubmed-article:3403105 | pubmed:meshHeading | pubmed-meshheading:3403105-... | lld:pubmed |
pubmed-article:3403105 | pubmed:meshHeading | pubmed-meshheading:3403105-... | lld:pubmed |
pubmed-article:3403105 | pubmed:meshHeading | pubmed-meshheading:3403105-... | lld:pubmed |
pubmed-article:3403105 | pubmed:meshHeading | pubmed-meshheading:3403105-... | lld:pubmed |
pubmed-article:3403105 | pubmed:year | 1988 | lld:pubmed |
pubmed-article:3403105 | pubmed:articleTitle | Pharmacokinetic study on piroxicam at the steady-state in elderly subjects and younger adults after administration of piroxicam beta-cyclodextrin. | lld:pubmed |
pubmed-article:3403105 | pubmed:affiliation | Pharmacotoxicological Research Laboratories, Chiesi Farmaceutici S.p.A., Parma, Italy. | lld:pubmed |
pubmed-article:3403105 | pubmed:publicationType | Journal Article | lld:pubmed |